C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 217/24 (2006.01) A61K 31/472 (2006.01) A61P 3/06 (2006.01)
Patent
CA 2676066
The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity.
La présente invention concerne une nouvelle classe d'agents se liant aux récepteurs nucléaires (NRBA). Les NRBA sont destinés à une utilisation dans la prévention et/ou le traitement d'une variété de maladies et de conditions comprenant la prévention et le traitement de cancers tels que le cancer de la prostate et le cancer du sein, l'ostéoporose, les maladies associées aux hormones, les maladies inflammatoires, les troubles associés au stress oxydatif tels que la maladie de Parkinson et l'accident vasculaire cérébral, les troubles neurologiques, les troubles ophtalmiques, les maladies cardiovasculaires, et l'obésité.
Dalton James T.
Hong Seoung-Soo
Miller Duane D.
Mohler Michael L.
Srivastava Devesh
Gtx Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Nuclear receptor binding agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nuclear receptor binding agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nuclear receptor binding agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1374401